Costo-beneficio del contrato bajo modalidad de cápita en el programa de diabetes mellitus de una ips en Huila, 2019.

Abstract

This degree work makes a cost benefit analysis of the contract under the capita modality in the RCV-DM program in a Primary IPS in Huila, 2019. It seeks to describe the cost structure and the contracting modality of the program, determine the cost- efficiency of the same and propose alternatives for changes to the EAPB. The methodology has a quantitative, descriptive, retrospective research approach with cost-benefit microeconomic analysis to the Cardiovascular Risk program. The primary source of information was the RIPS and technical note of the program for this provider. As a result, it is identified that the contract under the capita modality is not necessarily an efficient mechanism to control the cost for this diagnosis, because by not achieving clinical goals of the users, they lead to complications of the pathology that end up in a complementary network consuming the cost per claim